Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Depreciation & Amortization (CF) (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Depreciation & Amortization (CF) data on record, last reported at $6000.0 in Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) fell 97.22% year-over-year to $6000.0; the TTM value through Sep 2025 reached $126000.0, down 87.61%, while the annual FY2024 figure was $833000.0, 48.16% down from the prior year.
  • Depreciation & Amortization (CF) reached $6000.0 in Q3 2025 per GOSS's latest filing, roughly flat from $6000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $500000.0 in Q1 2022 and bottomed at $6000.0 in Q1 2025.
  • Average Depreciation & Amortization (CF) over 4 years is $286000.0, with a median of $292000.0 recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): grew 12.38% in 2023, then plummeted 97.68% in 2025.
  • A 4-year view of Depreciation & Amortization (CF) shows it stood at $420000.0 in 2022, then crashed by 30.48% to $292000.0 in 2023, then crashed by 63.01% to $108000.0 in 2024, then plummeted by 94.44% to $6000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $6000.0 in Q3 2025, $6000.0 in Q2 2025, and $6000.0 in Q1 2025.